Par Sterile Acquisition (Tables) (Par Sterile [Member])

12 Months Ended

Dec. 31, 2014

Par Sterile [Member]

Business Combination, Source of Funds and Use of Funds for Acquisition

The sources and uses of funds in connection with the Par Sterile Acquisition are summarized below ($ in thousands):



Sources:				Uses:
	Senior secured term loan	$	395,000		Cash purchase of equity	$	487,429	(a)
	Sponsor equity contribution	110,000			Transaction costs	12,350
	Company cash on hand	1,133		(a)	Accrued interest on Company debt	6,354
	Total source of funds	$	506,133		Total use of funds	$	506,133

(a)	Adjusted to reflect the finalization of working capital adjustments noted above.

Schedule of Business Combination, Allocation of Assets and Liabilities

The purchase price of Par Sterile has been allocated to the following assets and liabilities ($ in thousands):



	As of February 20, 2014
Cash and cash equivalents	$	9,204
Accounts receivable, net	5,413
Inventories	35,959
Prepaid expenses and other current assets	10,583
Property, plant and equipment	73,579
Intangible assets	283,500

Total identifiable assets	418,238

Accounts payable	13,796
Accrued expenses and other liabilities	1,902
Deferred tax liabilities	71,493

Total liabilities assumed	87,191

Net identifiable assets acquired	331,047

Goodwill	156,382

Net assets acquired	$	487,429

Schedule of Supplemental Pro Forma Information

The following unaudited pro forma information for the years ended December 31, 2014 , and December 31, 2013 assumes the Par Sterile Acquisition occurred as of January 1, 2013. The pro forma information is not necessarily indicative either of the combined results of operations that actually would have been realized had the acquisition been consummated during the periods for which pro forma information is presented, nor is it intended to be a projection of future results or trends.



	For the Year Ended
(In thousands)	December 31, 2014			December 31, 2013
Total revenues	$	1,327,683		$	1,249,682
Net loss	$	(97,444	)	$	(136,599	)